| Useful Advices |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Sales Training > There Is Only One Problem With Negative Selling! |
|
Useful Advices - There Is Only One Problem With Negative Selling!
I have a Chicago based client that has taken a sales training course that According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product encourages the use of negativity, and he absolutely, unconditionally, and ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in irretrievably has fallen in love with it. I asked him for some details, a lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. d he recited the overall philosophy of the course, I’m sure, just as he ha here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe d been indoctrinated to do: “The idea,” he said, “is that most sales guru d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro s suggest using a positive mental attitude, acting and sounding positive, ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc nd this just seems too-good-to-be-true to today’s buyers!” So, how does t easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi his translate into techniques? “I might call a prospect and say I’ve been nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically able to help a lot clients, but I may or may not be able to help you.” A and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ d they like this? “Well, yes; a lot of them do, and I go on to say I migh ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi t be able to save them about five grand over the next twelve months, but t ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a hat may not be enough of a savings to interest them.” How do they respond dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod “They say, no, that’s real money; maybe we should talk!” And he adds cl cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin ients this way. I don’t doubt that this approach works a certain amount o tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen f the time. Let’s say it works 50% of the time, and a more positive appro t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel ch works 50% of the time. Then, you can choose, and come out the same pla ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust ce, right? Not really. As I see it, the only drawback would be that you a y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products re spending 100% of your time sounding negative, putting on your books cli . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de nts who are driven by and who respond to negativity, to cynicism. Is this elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip really how you want to feel, and with whom you want to interact every day tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:How Import Companies Can Benefit from Purchase Order Financing Business Debt Consolidation - Business Debt Consolidation Gets Businesses on Track It's Not What You Ask - It's How You Ask It!
|